001 Prevention of potential sexual transmission of Zika virus-20160218(WHO)
002 Maintaining a safe and adequate blood supply during Zika virus outbreaks, interim guidance-20160219(WHO)
003FDA issues recommendations to reduce the risk for Zika virus blood transmission in the United States-20160216(FDA)
004 Recommendations for Donor Screening, Deferral, and Product Management to Reduce the Risk of Transfusion-Transmission of Zika Virus-20160216(FDA)
005 Update: Interim Guidelines for Prevention of Sexual Transmission of Zika Virus — United States, 2016-20160223(WHO)
006 Interim Guidelines for Prevention of Sexual Transmission of Zika Virus